Skip to main content

CME GROUP INC.

For the period ended Dec 31, 2025. Filed Mar 23, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Dec 31, 2025 · Filed Mar 23, 2026

CME$305.89-0.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

2026 PROXY STATEMENTCME GROUPA-3

2026 PROXY STATEMENTCME GROUPA-3
Appendix ATABLE OF CONTENTS
CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Operating Income
(dollars in millions)
Year Ended December 31,
202520242023
Total Revenues$6,520.6$6,130.1$5,578.9
Real estate-related (costs) credits—(1.0)—
Adjusted Total Revenues$6,520.6$6,129.1$5,578.9
Total Expenses$2,291.1$2,198.6$2,143.2
Restructuring and severance(14.8)(11.3)(17.6)
Deferred compensation(1)(14.2)(15.9)(16.6)
Amortization of purchased intangibles(223.4)(221.7)(226.6)
Strategic transaction-related (costs) credits(23.6)(0.8)(9.3)
Real estate-related (costs) credits6.71.1—
Foreign exchange transaction gains (losses)(6.1)(2.9)(12.9)
Unrealized and realized gains (losses) on assets(0.5)(0.9)(1.3)
Litigation matters or settlements(19.4)(1.2)(10.6)
Adjusted Total Expenses$1,995.8$1,945.0$1,848.3
Operating Income$4,229.5$3,931.5$3,435.7
Adjusted Operating Income$4,524.8$4,184.1$3,730.6
Adjusted Operating Margin69.4%68.3%66.9%
1. Includes $14.2 million for a change in our non-qualified deferred compensation liability for the full-year 2025. This impact does not affect net income or adjusted net income, as the compensation and benefits change has an equal and offsetting change in investment income.
A-4CME GROUP2026 PROXY STATEMENT
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.